10/28/2024
7:22 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
7:13 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
11:15 PM | Acasti Pharma (Filer)
| Form EFFECT | |
10/15/2024
11:15 PM | Acasti Pharma (Filer)
| Form EFFECT | |
10/08/2024
6:22 AM | Acasti Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/08/2024
6:13 AM | Acasti Pharma (Filer)
| Form POS AM | |
10/08/2024
6:15 AM | Acasti Pharma (Filer)
| Form POS AM | |
|
10/08/2024
6:16 AM | Acasti Pharma (Filer)
| Form S-8 POS | |
10/08/2024
6:16 AM | Acasti Pharma (Filer)
| Form S-8 POS | |
10/08/2024
6:16 AM | Acasti Pharma (Filer)
| Form S-8 POS | |
09/30/2024
3:31 PM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
7:00 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
7:00 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:30 AM | Acasti Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
3:14 PM | Acasti Pharma (Filer)
| Form 424B3 | |
08/04/2024
11:15 PM | Acasti Pharma (Filer)
| Form EFFECT | |
07/31/2024
6:22 AM | Acasti Pharma (Filer)
| Form S-4/A | |
07/11/2024
10:16 AM | Acasti Pharma (Issuer)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
| Form 3/A | |
07/10/2024
8:10 PM | Acasti Pharma (Subject)
ADAR1 Capital Management, LLC (Filed by)
| Form SC 13G | |
07/09/2024
7:29 PM | Acasti Pharma (Issuer)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/27/2024
4:01 PM | Acasti Pharma (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
06/21/2024
7:00 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
6:30 AM | Acasti Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
05/08/2024
6:18 PM | Acasti Pharma (Issuer)
Kohli Prashant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:18 PM | Acasti Pharma (Issuer)
DelAversano Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:19 PM | Acasti Pharma (Issuer)
Macdonald R. Loch (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:19 PM | Acasti Pharma (Issuer)
Kumar Amresh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:19 PM | Acasti Pharma (Issuer)
D'Andrea Carrie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
7:46 AM | Acasti Pharma (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
04/01/2024
7:00 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
6:03 PM | Acasti Pharma (Subject)
BANK OF AMERICA CORP /DE/ (Filed by)
| Form SC 13G | |
02/12/2024
7:00 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
6:30 AM | Acasti Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
01/08/2024
7:00 AM | Acasti Pharma (Issuer)
DelAversano Robert J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2024
6:30 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
6:30 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
7:10 AM | Acasti Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:30 AM | Acasti Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
